Paper35530735
Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review.
Zou H and 8 others. Front Public Health, 2022. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review. Papers, record 35530735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35530735
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Adult | |
| China | |
| Financial Stress | |
| Humans | |
| Quality of Life |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06419478 | Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis | Results |
Source ClinicalTrials.gov
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11980994 | Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/11980994 | PubMed |
| 2 | 30776212 | Humanistic and economic burden of hepatocellular carcinoma: systematic literature review. | Am J Manag Care | 2019 | https://conductscience.org/library/papers/30776212 | PubMed |
| 3 | 28052758 | Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28052758 | PubMed |
| 4 | 18471552 | Diagnosis and treatment of hepatocellular carcinoma. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18471552 | PubMed |
| 5 | 31768732 | Impact of the disclosure of diagnosis on posttraumatic stress and growth and quality of life in Chinese patients with hepatocellular carcinoma. | Support Care Cancer | 2020 | https://conductscience.org/library/papers/31768732 | PubMed |
| 6 | 26054909 | Advances in targeted therapies for hepatocellular carcinoma in the genomic era. | Nat Rev Clin Oncol | 2015 | https://conductscience.org/library/papers/26054909 | PubMed |
| 7 | 26567897 | Impact of disclosure of diagnosis and patient autonomy on quality of life and illness perceptions in Chinese patients with liver cancer. | Psychooncology | 2016 | https://conductscience.org/library/papers/26567897 | PubMed |
| 8 | 12187175 | Estimating health care costs related to cancer treatment from SEER-Medicare data. | Med Care | 2002 | https://conductscience.org/library/papers/12187175 | PubMed |
| 9 | 30486324 | Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan. | Int J Environ Res Public Health | 2018 | https://conductscience.org/library/papers/30486324 | PubMed |
| 10 | 15042359 | Randomized controlled trial of screening for hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2004 | https://conductscience.org/library/papers/15042359 | PubMed |
| 11 | 27281033 | The Role of Age in Change in Unmet Supportive Care Needs in Hepatocellular Carcinoma Patients During Transition From Hospital to Home. | Cancer Nurs | 2017 | https://conductscience.org/library/papers/27281033 | PubMed |
| 12 | 24764650 | Hepatocellular carcinoma review: current treatment, and evidence-based medicine. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24764650 | PubMed |
| 13 | 22519878 | Mini-nutritional assessment predicts functional status and quality of life of patients with hepatocellular carcinoma in Taiwan. | Nutr Cancer | 2012 | https://conductscience.org/library/papers/22519878 | PubMed |
| 14 | 31040713 | Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31040713 | PubMed |
| 15 | 18405598 | [Evaluation of Chinese version of the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire]. | Zhong Xi Yi Jie He Xue Bao | 2008 | https://conductscience.org/library/papers/18405598 | PubMed |
| 16 | 19622511 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19622511 | PubMed |
| 17 | 2509745 | Clinical economics. A guide to the economic analysis of clinical practices. | JAMA | 1989 | https://conductscience.org/library/papers/2509745 | PubMed |
| 18 | 20304101 | Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. | Clin Gastroenterol Hepatol | 2010 | https://conductscience.org/library/papers/20304101 | PubMed |
| 19 | 19622552 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. | BMJ | 2009 | https://conductscience.org/library/papers/19622552 | PubMed |
| 20 | 19302335 | Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. | J Viral Hepat | 2009 | https://conductscience.org/library/papers/19302335 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959463 | Patient-reported financial toxicity among patients with liver cancer: a systematic review and meta-analysis. | Front Public Health | 2026 | https://conductscience.org/library/papers/42959463 | PubMed |
| 41951898 | EcoRxAgent: an AI agent for generating economically substitutable prescriptions. | NPJ Digit Med | 2026 | https://conductscience.org/library/papers/41951898 | PubMed |
| 41827595 | Breathing Exercise for Chronic Pain Management in Breast Cancer Survivors: Feasibility Outcomes and Qualitative Insights from a Pilot Randomised Controlled Trial. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/41827595 | PubMed |
| 41815170 | Construction and validation of a prognostic model associated with chromatin remodeling in hepatocellular carcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41815170 | PubMed |
| 41640958 | Evaluation of the impact of an interdisciplinary team scheduling model on psychological outcomes in patients with decompensated cirrhosis. | World J Hepatol | 2026 | https://conductscience.org/library/papers/41640958 | PubMed |
| 41595249 | Two-Stage Microwave Hyperthermia Using Magnetic Nanoparticles for Optimal Chemotherapy Activation in Liver Cancer: Concept and Preliminary Tests on Wistar Rat Model. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41595249 | PubMed |
| 41411278 | Efficacy and safety of Atezolizumab plus Bevacizumab and Lenvatinib as first-line systemic therapies for hepatocellular carcinoma: A real-world study. | PLoS One | 2025 | https://conductscience.org/library/papers/41411278 | PubMed |
| 41148426 | CCL20 mediates the effect of cathepsin S on hepatocellular carcinoma development insights from Mendelian randomization and bioinformatics analysis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41148426 | PubMed |
| 41035085 | Critical analysis of the liver cancer policies and programs in China: implications for international liver cancer control. | Glob Health Res Policy | 2025 | https://conductscience.org/library/papers/41035085 | PubMed |
| 40735995 | Cancer Cell-Coated PLGA Nanoparticles Loaded with Sorafenib and Spions for Hepatocellular Carcinoma Theranostics. | Curr Drug Deliv | 2026 | https://conductscience.org/library/papers/40735995 | PubMed |
| 40670432 | Analysis of factors influencing tumor volume doubling time in hepatocellular carcinoma and its predictive value for progression-free survival. | Sci Rep | 2025 | https://conductscience.org/library/papers/40670432 | PubMed |
| 40523760 | Identification of prognosis-related key genes in hepatocellular carcinoma based on bioinformatics analysis. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | https://conductscience.org/library/papers/40523760 | PubMed |
| 40516009 | Single cell analysis and bioinformatics reveal pyroptosis mechanisms in hepatocellular carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40516009 | PubMed |
| 40507701 | Determinants of Health-Related Quality of Life After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients: A Systematic Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40507701 | PubMed |
| 40504321 | Radiofrequency Ablation Technology in Liver Malignancies: A Systematic Review of Economic Evaluations. | J Gastrointest Cancer | 2025 | https://conductscience.org/library/papers/40504321 | PubMed |
| 40502525 | Multidisciplinary treatment strategies for the assessment of immune, coagulation, and biomarker responses after transarterial chemoembolization for hepatocellular carcinoma. | World J Gastrointest Surg | 2025 | https://conductscience.org/library/papers/40502525 | PubMed |
| 40188134 | Psychosocial factors associated with quality of life in cancer patients undergoing treatment: an umbrella review. | Health Qual Life Outcomes | 2025 | https://conductscience.org/library/papers/40188134 | PubMed |
| 39820759 | Exploring early postoperative core symptoms in Chinese patients with primary liver cancer: a cross-sectional and longitudinal network analysis. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/39820759 | PubMed |
| 39609433 | A brain-to-liver signal mediates the inhibition of liver regeneration under chronic stress in mice. | Nat Commun | 2024 | https://conductscience.org/library/papers/39609433 | PubMed |
| 39598228 | The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39598228 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| ALPP | 250 | PubTator's text mining | https://conductscience.org/library/genes/250 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35530735
GET https://conductscience.org/api/papers/v1/35530735/references?page=2